Posted inMarket
PYC Therapeutics Q3 2026 Earnings Beat Expectations Driven by Strong Trial Data
Discover how PYC Therapeutics surpassed Q3 2026 earnings per share estimates, fueled by positive clinical trial results and an upgraded outlook.
Posted inMarket
eGain Q4 Financial Results Show Earnings Beat Alongside Revenue Shortfall
eGain released its latest financial report, revealing an earnings per share beat alongside a slight revenue miss compared to analyst expectations.
